NMS·Healthcare·$379M·#179 / 520 in Healthcare
SOPH SOPHiA GENETICS SA
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH30
QUALITY58
STABILITY57
VALUATION71
GOVERNANCE71
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+18.6%
30
> 50% strong
Gross Margin
Revenue retained after direct costs
67.4%
96
> 50% strong
Cash Runway
Months of cash at current burn rate
23 months
83
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
133.7%
3
< 25% strong
Price / Sales
Market cap relative to trailing revenue
4.9x
71
< 3x strong
Rule of 40
Growth rate plus operating margin
-73
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
8.4%
57
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-9.6%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SOPH WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SOPH's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.